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Abstract
The goal of this research was to investigate the reasons behind the plethora of amendments of the
FASB Accounting Pronouncements for Financial Instruments from 2002 to 2008. Entities have
communicated their apprehensions that the existent disclosure requirements in SFAS No. 133,
“Accounting for Derivative Instruments and Hedging Activities”, do not furnish sufficient input
about how derivative and hedging activities influence an entity’s financial position, financial performance, and cash flows. Correspondently, in 2008 the FASB issued Statement No. 161, “Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No.
133”. The purpose of the study was to investigate the extent to which the thirty companies that
comprise the Dow Jones Industrial Average complied with the new qualitative and quantitative
disclosure requirements for derivative financial instruments of SFAS No. 161. Following the theoretical framework of corporate risk management, the quarterly financial statements (10Qs) of the
thirty companies that comprise the Dow Jones Industrial Average were examined to determine
whether companies complied with the qualitative requirements of SFAS No.161 to disclose their
objectives for holding or issuing derivative financial instruments and their risk management policy as well as a description of the items being hedged. A surprising finding was that most companies failed with the requirements of SFAS No. 161 to disclose the required information about cash
flow hedges, net investments in foreign operations and, fair value hedges. These findings suggest
that although the FASB issued SFAS No. 161 to enhance derivative disclosures to enable users of
financial statements to evaluate the success and significance of derivative instruments and hedging transactions on an entity’s financial statements, companies might need additional time to implement the standard.
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1. Introduction

The application and complication of derivative instruments and hedging activities have intensified substantially
over the past several years. Entities have communicated their apprehensions that the existent disclosure requirements in FASB Statement No. 133, “Accounting for Derivative Instruments and Hedging Activities”, do
not furnish sufficient input about how derivative and hedging activities influence an entity’s financial position,
financial performance, and cash flows. Correspondently, the FASB issued Statement No. 161, “Disclosures
about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133”. In 1986,
the Financial Accounting Standards Board (FASB) added a major project of financial instruments to its agenda.
The project was motivated by the emergence of innovative new financial instruments used by companies for risk
management and by companies and investors for speculation. The focus is on the FASB for financial instruments accounting pronouncements. Between 1990 and 2008, the FASB issued numerous accounting standards
pertaining to financial instruments as shown below:
FASB Statement No. 105, “Disclosure of Information about Financial Instruments with Off-Balance-Sheet
Risk and Financial Instruments with Concentrations of Credit Risk”, (Issue Date 3/90): FASB Statement No.
105, established disclosure information for derivative instruments with “off-balance-sheet risk of accounting
loss”. This Statement centralized on the credit risk for all derivative instruments representing the first phase on
disclosing information about the “extent, nature, and terms of financial instruments with off-balance-sheet credit
or market risk”. The succeeding disclosure phases of the Board’s project contemplated additional disclosure requirement and “recognition and measurement issues” for derivative instruments and off-balance-sheet financing.
This Statement prolonged existing disclosure requirements for derivative instruments by compelling the following disclosure information about financial instruments with off-balance-sheet risk of accounting loss: (1) “the
face, contract, or notional principal amount”, and (2) “the nature and terms of the instruments and a discussion
of their credit and market risk, cash requirements, and related accounting policies”. Additionally, this Statement
required disclosure information about an entity’s policy for collateral or other security on derivative instruments
since companies could not recognize an accounting loss caused by the failed execution of the terms of the contract of any party to the financial instrument. This Statement was effectual for financial statements released for
fiscal years ending after June 15, 1990.
FASB Statement No. 107, “Disclosures about Fair Value of Financial Instruments”, (Issue Date 12/91): FASB
Statement No. 107 amplified the existent fair value disclosure requirements for derivative instruments by compelling the disclosure of fair value for both derivative assets and derivative liabilities identified and not identified in the statement of financial position, for which the fair value evaluation was achievable. In the contrary,
companies required explanatory disclosures apposite to the value of a derivative instrument where the fair value
assessing was not feasible. This Statement became effective for financial statements issued for fiscal years ending after December 15, 1992, with the exclusion of companies with less than $150 million in total assets in the
current statement of financial position for which effective date was for fiscal years ending after December 15,
1995.
FASB Statement No. 119, “Disclosure about Derivative Financial Instruments and Fair Value of Financial Instruments”, (Issue Date 10/94): FASB Statement No. 119 remarked disclosures about derivative financial instruments such as futures, forward, swap, and option contracts, and other financial instruments with analogous
features by requiring disclosures about the “amounts, nature, and terms of derivative financial instruments held
or issued for trading intentions and financial instruments held or issued for purposes other than trading". This
Statement required disclosure of the average fair value and of the net trading gains and losses of trading derivative instruments and the purpose of holding or issuing derivative financial instruments other than trading reported in the financial statements. Additionally, companies that hold or issue derivative financial instruments
and account for them as hedging transactions, this Statement required disclosure about the predicted agreements,
the determination of asset derivatives and liability derivatives used for hedging those transactions, the hedging
gains and losses deferred, and the transactions resulted in identification of the deferred gains or losses in earnings. SFAS No. 119 also amended the existing requirements of FASB Statement No. 105, “Disclosure of Information about Financial Instruments with Off-Balance-Sheet Risk and Financial Instruments with Concentrations
of Credit Risk”, and FASB Statement No. 107, “Disclosures about Fair Value of Financial Instruments.” This
Statement amended Statement 105 to need disaggregation of information by asset-liability class, business activity, risk, and management of derivative financial instruments with off-balance-sheet risk of accounting loss. Additionally, SFAS No. 119 amended Statement 107 to require that fair value information and the related carrying
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amounts of derivative assets and derivative liabilities be presented in the financial statements without merging,
aggregating, or netting the fair value of derivative financial instruments with the fair value of no derivative financial instruments. SFAS No. 119 became effective for financial statements issued for fiscal years ending after
December 15, 1994, except for entities with less than $150 million in total assets for which it became effective
for fiscal years ending after December 15, 1995.
FASB Statement No. 133, “Accounting for Derivative Instruments and Hedging Activities”, (Issue Date 6/98):
SFAS No. 133 became effective for all fiscal quarters of fiscal years beginning after June 15, 1999 substantiating accounting and reporting standards for derivative instruments, embedded derivatives and hedging activities.
Those standards include the identification in the statement of financial position of all derivatives as either assets
or liabilities accounted for at fair value. According to SFAS No. 133 if specific conditions are met, a derivative
could particularly designated as (a) “a fair value hedge, a hedge of the exposure to changes in the fair value of a
recognized asset or liability or an unrecognized firm commitment”, (b) “a cash flow hedge, a hedge of the exposure to variable cash flows of a forecasted transaction”, or (c) “a hedge of the foreign currency exposure of a
net investment in a foreign operation, an unrecognized firm commitment, an available-for-sale security, or a foreign-currency-denominated forecasted transaction”. Under SFAS No. 133, a company-practicing hedge accounting is needed to demonstrate at the initiation of the hedge the approach it will exercise for valuing the effectiveness of the hedging derivative and the measurement approach for deciding the ineffective aspect of the
hedge. Those approaches must be uniform with the entity’s approach to managing risk. The accounting for the
gains and losses resulting from variations in the fair value of a derivative pivots on the considered purpose of the
derivative and the resulting designation. Initially, Fair value hedge accounting portrays in income the degree to
which the hedge is not effective in attaining balancing out changes in fair value by identifying the gain or loss
from fair value hedges in income in the time of change in conjunction with the counterbalancing loss or gain on
the hedged item assignable to the risk being hedged. Succeeding, cash flow hedge accounting represents initial
reporting of the effective portion of the derivative’s gain or loss as a component of other comprehensive income
and afterwards reclassified into income when the forecasted transaction affects earnings while the ineffective
portion of the gain or loss is reported in earnings directly. Subsequently, for a derivative designated as hedging
the foreign currency exposure of a net investment in a foreign operation, the gain or loss is stated in other comprehensive income as part of the accumulative conversion change. The accounting for fair value hedging addresses derivatives designated as a hedge of the foreign currency exposure of an unrecognized firm commitment
or an available-for-sale security. Likewise, the accounting for a cash flow hedge applies to a derivative designated as a hedge of the foreign currency exposure of a foreign-currency-denominated forecasted transaction.
Lastly, derivatives not designated as a hedging instrument, the gain or loss is recognized in earnings in the period of change.
FASB Statement No. 137, “Accounting for Derivative Instruments and Hedging Activities—Deferral of the
Effective Date of FASB Statement No. 133—an amendment of FASB Statement No. 133”, (Issue Date 6/99):
FASB Statement No. 137 delayed the effective date of SFAS No. 133 for all fiscal quarters of all fiscal years
beginning after June 15, 2000 under the requests of entities and their auditors wishing more time to study, understand, and implement the provisions of Statement 133 and complete information system modifications. Additionally, Statement 137 replaced paragraph 50 of SFAS No. 133 by requiring entities at the date of initial application to choose to either (a) “recognize as an asset or liability in the statement of financial position all embedded derivative instruments that are required to be separated from their host contracts” or (b) “select either January 1, 1998 or January 1, 1999 as a transition date for embedded derivatives”. This Statement was taken by
adoption by the assenting votes of five members of the Financial Accounting Standards Board. The two Board
members who dissented Mr. Cope and Mr. Foster were apprehensive that users of financial statements would
recommence as to be disadvantaged from essential information to investment decision-making process supporting that the advantages of procrastinating implementation of SFAS No. 133 does not compensate for the benefits
of actuate implementation.
FASB Statement No. 155, “Accounting for Certain Hybrid Financial Instruments—an amendment of FASB
Statements No. 133 and 140”, (Issue Date 02/06): This Statement became effective for all financial instruments
acquired or issued after September 15, 2006 requiring that the fair value appointment may be implemented upon
adopting this Statement for hybrid financial instruments that had been bifurcated prior to the adoption of this
Statement. This Statement resolved the concerns referred in Statement 133 Implementation Issue No. D1 concerning the implementation of the bifurcation requirements of beneficial interests in securitized financial assets.
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Statement 155 resolved the bifurcation requirements by (a) allowing fair value re-measurement for any hybrid
financial instrument that comprises an embedded derivative that would need bifurcation to be re-measured at fair
value, and (b) substantiated essentials to value interests in securitized financial assets to distinguish interests that
are freestanding derivatives or that are hybrid financial instruments that comprise an embedded derivative requiring bifurcation. Statement No. 155 provisions applied to derivative instruments held by an entity at the date
of adoption on an “instrument-by-instrument basis” with the difference between the total carrying value of the
existent bifurcated hybrid financial instrument and the fair value of the combined hybrid financial instrument
acknowledged to beginning retained earnings as a cumulative-effect adjustment separating aggregate gain positions from loss positions determined on an instrument-by-instrument basis. This Statement ameliorated financial
reporting by excluding application of Statement 133 to interests in securitized financial assets enforcing similar
instruments to be accounted for alike regardless of the form of the instruments and by permitting companies to
designate the fair value measurement at purchase, issuance, or when a previously recognized financial instrument was subject to re-measurement, on an instrument-by-instrument basis, in cases in which a derivative would
otherwise have to be bifurcated. Providing a fair value measurement appointment additionally culminated in
more financial instruments being calculated at what the Board valued as the most pertinent attribute for financial
instruments, fair value.
FASB Statement No. 161, “Disclosures about Derivative Instruments and Hedging Activities—an amendment
of FASB Statement No. 133”, (Issue Date 03/08): This Statement changes the disclosure requirements for derivative instruments and hedging activities. Entities are required to provide enhanced disclosures about (a) “how
and why an entity uses derivative instruments”, (b) “how derivative instruments and related hedged items are
accounted for under Statement 133 and its related interpretations”, and (c) “how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows”. This Statement
is deliberated to ameliorate financial reporting by improving the current disclosure framework presented in
Statement 133. SFAS No. 161 requires disclosing the objectives for using derivative instruments kindred to underlying risk and accounting designation to convey the objectives of derivative use in terms of the risks that the
entity is aspiring to control. Consequently, SFAS No. 161 requires in a tabular format the disclosure of the gains
or losses resulting from changes in fair value of derivative instruments furnishing users of financial statements a
more complete picture of the derivative assets and liabilities and the effect of using those derivatives during the
reporting period. Additionally, an entity should disclose information about credit-risk-related contingent features
to provide users of financial statements with information on the potential effect on an entity’s liquidity from using derivatives. Finally, this Statement requires cross-referencing within the footnotes, which should help users
of financial statements locate important information about derivative instruments.

2. Accounting for Derivatives and Hedging Activities
The main issue in accounting for derivatives is the treatment of the gains and losses resulting from the change of
the derivative’s carrying value to fair value since all derivatives are reported on the balance sheet at fair value
and fair value can change from period to period. Furthermore, since the main objective of hedging is to secure
the income statement from the impact of opposed changes in prices, interest rates, or currency exchange rates,
companies exercising derivatives for hedging would like to use an accounting approach that causes the gain or
loss from the derivative to impact earnings in the equivalent period as the gain or loss resulting from the risk
being hedged. This accounting approach is referred to as hedge accounting. Hedge accounting is allowed only if
several conditions are met. The three most important of these conditions relate to (1) “the nature of the hedged
risk”, (2) “the hedge effectiveness”, and (3) “documentation”. If any of these conditions is not met, hedge accounting is not allowed, and any change in the carrying value of the derivative must be recognized immediately
in earnings.

2.1. Proposed Amendment of SFAS 133: Hedge Effectiveness
Hedged risks that allow a derivative to qualify for hedge accounting include (1) interest rate risks, (2) price risks,
(3) foreign currency exchange rate risks, and (4) credit risks. Derivatives used to hedge these risks can be designed as hedges of three types of risk exposures: (1) fair value exposure, (2) cash flow exposure, and (3) exposure to changes in the value of a net investment in a foreign operation. For a derivative designated as hedging
the exposure to changes in the fair value of a recognized asset or liability or a firm commitment (referred to as a
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fair value hedge), the gain or loss is recognized in earnings in the period of change together with the offsetting
loss or gain on the hedged item attributable to the risk being hedged. The effect of that accounting is to reflect in
earnings the extent to which the hedge is not effective in achieving offsetting changes in fair value. For a derivative designed as hedging the exposure to variable cash flows of a forecasted transaction referred to as a cash
flow hedge, “the effective portion of the derivative’s gain or loss is initially reported as a component of other
comprehensive income (outside earnings) and subsequently reclassified into earnings when the forecasted
transaction affects earnings. The ineffective portion of the gain or loss is reported in earnings immediately. For a
derivative designated as hedging the foreign currency exposure of a net investment in a foreign operation, the
gain or loss is reported in other comprehensive income (outside earnings) as part of the cumulative translation
adjustment” (FASB No. 133, p. 5).
Hedge effectiveness relates to the capability of the derivative instrument to originate gains and losses that
counteract losses and gains on the hedged item. For hedge accounting to be used, a company must anticipate that
the hedge will be highly effective in offsetting for changes in the value of the hedged item or changes in cash
flows connected to the hedged item. After the hedge is in place, it must practically be highly effective to continue the use of hedge accounting. Effectiveness tests can be based on changes in the value of the complete hedged
instrument or can omit changes in the value related to course of time. For example, futures and forward prices
can be viewed as the total of the current spot price plus a forward discount or premium. The change in forward
discount or premium is unrelated to any changes in an item where futures are used to hedge, so a valid approach
is to exclude the changes in discount or premium from the measurement of hedge effectiveness. In this case,
hedge effectiveness would be evaluated by comparing changes in the spot rate component of futures prices to
changes in the value of the hedged item. Accordingly, the company must select a method to measure the portion
of the change in the value of the derivative intended to offset changes in the hedged exposure and to evaluate
hedge effectiveness (1) at the inception of the hedge and (2) on an ongoing basis while the hedge is in place
(Trombley, 2003: p. 35).
The Financial Accounting Standards Board issued on November 6, 2008 an exposure draft of the proposed
amendment of FASB Statement No. 133. This proposed Statement would amend the hedge effectiveness guidance in Statement 133 to no longer require (a) that a hedging relationship be highly effective, (b) a quantitative
assessment of the effectiveness of a hedging relationship, or (c) ongoing effectiveness testing. This proposed
Statement would require that a hedging relationship be “reasonably effective” and not “highly effective”. The
Board decided to amend the hedge effectiveness specifications in Statement 133 to diminish the complication of
qualifying for hedge accounting, make it simpler for entities to regularly execute hedge accounting, and furnish
comparability and uniformity in financial statement results. It would also require a qualitative assessment of the
hedging relationship’s effectiveness at inception of the hedging relationship and only in specific conditions,
would require a quantitative assessment to illustrate that changes in fair value of the hedging instrument are anticipated to be reasonably effective in offsetting changes in fair value of the hedged item or variability in cash
flows of the hedged transaction. Finally, entities after inception of the hedging relationship would need to qualitatively or quantitatively reevaluate effectiveness only if incidents evoke that the hedging relationship may no
longer be reasonably effective (FASB Exposure Draft amendment of SFAS No. 133, 2008).

2.2. Methods of Testing Hedge Effectiveness
As Trombley (2003) states, the hedge must be expected to be highly effective in achieving gains and losses that
offset gains and losses on the hedged risk at the inception of the hedge. The two acceptable approaches for assessing expected effectiveness are “critical terms analysis” and “statistical analysis”. Critical term analysis assesses the critical terms including the nature of the underlying, the notional amount of the derivative, and the
actual amount of the hedged item, the delivery date, and the settlement date. If the critical terms of the hedged
item and the hedging instrument match, effective hedging can reasonably be assumed. If critical terms analysis
fails because the critical terms of the hedged item and the hedging instrument do not match, the alternative is
statistical analysis. There are three primary methods of testing the hedging effectiveness of forwards, futures,
and swaps when the critical terms of the hedging derivative and the hedged item are not identical: (1) “the dollar-offset method”, and (2) the “regression method” (Finnerty, & Grant, n.d.).
Dollar-Offset Method: Finnerty et al. (n.d.) determines that the dollar-offset method evaluates the fair value or
cash flow changes of the hedged item and the derivative. The change in the value of the derivative closely counteracts the change in the value of the hedged item under a highly effective hedge. Consequently, in a highly ef-
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fective hedge the ratio of the lump sum of the intermittent changes in the value of the derivative and the hedged
item would equal one “after multiplying the ratio by negative one to adjust for the two sums having opposite
signs in a hedging relationship”. In a speech at the “SEC’s 1995 Annual Accounting Conference, a member of
the SEC’s Office of the Chief Accountant articulated an 80/125 standard for hedge effectiveness as measured by
the dollar-offset method”. Trombley (2003) explains that the cumulative dollar-offset method has emerged as a
standard practice and it calculates the delta ratio on a quarterly basis using cumulative changes in the value of
the derivative and the value of the hedged item. Although there is no authoritative standard for a minimum or
maximum delta ratio, common practice is to use the “80/125 standard”, that is, if the delta ratio falls outside the
range of 0.80 and 1.25, hedge accounting should be discontinued. In conformity to SFAS No. 133 entities
should use either a “period-by-period” approach or a “cumulative” approach retrospectively every quarter to assess the effectiveness of a fair value hedge or a cash flow hedge to achieve offsetting changes in fair values or
cash flows under the dollar-offset approach. The “period-by-period” approach requires contrasting the changes
arise throughout the assessed period of the hedging instrument’s fair values or cash flows to the changes in the
hedged item’s fair value or hedged transaction’s cash flows attributable to the hedged risk that have occurred
during the same period. The “cumulative” approach entails comparing the cumulative changes in the hedging
instrument’s fair values or cash flows to the cumulative changes in the hedged item's fair value or hedged transaction’s cash flows attributable to the risk hedged from the inception of the hedge until today. According to paragraphs 20(a) and 28(a) of SFAS No. 133, entities may select at the inception of the hedge either approach depending on the nature of the hedge documented to designate how effectiveness will be assessed (Derivatives
Implementation Group, DIG Issue No. E8, 2000).
Regression Method: Regression analysis is a statistical method that grants quantitative information about the
relationship between two or more variables. In the context of SFAS 133, the necessity to prove that a derivative
will be highly effective transcribes to display that the price or interest rate or currency exchange rate connected
with the hedged item sustains closeness to the price corresponding with the hedging derivative. Simple regression furnishes a summary statistic, the correlation coefficient, which quantifies the proximity of the relationship.
Correlation coefficients may range in value from −1.0 to +1.0, where 1.0 is expressive of a perfect correlation
between the two respective variables. A related statistic to the correlation coefficient is the coefficient of determination, or the R-Squared. The R-Squared is found simply by squaring the correlation coefficient, so the possible range of the R-Squared statistic is from zero to one. While SFAS 133 does not define how to determine
highly effective hedges from those that are less effective, the staff of the Securities and Exchange Commission
(SEC) has supported informally that a correlation of 0.90 or a R-Square of 0.80 is a satisfactory shortcut to
substantiate assumptions of hedge effectiveness (Kawaller, 2002).
Hedge Documentation: According to the Derivatives Implementation Group (DIG) Issue No. J3 (1999), the
designation and documentation of hedging relationships must be concurrent with the initial adoption date of
SFAS No. 133. At the inception of a fair value or cash flow hedge entities must provide formal documentation
of the “hedging relationship, the entity's risk management objectives and strategies for undertaking the hedge,
including identification of the hedging instrument, the hedged item, the nature of the risk being hedged, and the
method of assessing the hedging instrument's effectiveness” in reference to designating hedging relationships.
The Board requires concurrent designation and documentation of a hedge to prevent management’s intent to
attain a preferred hedge accounting result by prohibiting reviewing transactions with “hindsight” and making retroactive decisions after hedge results are acknowledged. Specifically, at the inception of a cash flow or a fair
value hedge, Statement 133 requires entities to provide documentation to indicate the period they anticipate the
forecasted transaction to transpire. After the date of initial application the designation and formal documentation
of a hedging relationship accomplish hedge accounting only prospectively with any gain or loss on the derivative recognized currently in earnings prospectively from the date of initial application (Derivatives Implementation Group (DIG) Issue No. J3, 1999).

2.3. Problems with the Application of SFAS 133
SFAS 133 made substantial progress in clearing up a great deal of confusion over the accounting for derivatives
project. Nonetheless, it left some problems unresolved and generated some lingering concerns. SFAS 133 does
not prescribe what constitutes effective hedging. Thus, there is some fear that restatements of earnings will be
required if later it is determined that the effectiveness test used by a firm is not acceptable. SFAS 133 also re-
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quire that some embedded derivatives be stripped out and valued. This can be extremely complex and is subject
to a wide margin of error. SFAS 133 does not permit hedge accounting for bonds designed to held- to- maturity.
It reflects the all-too-common and naïve view that as long as a bond is to be held to maturity, any losses in value
are ultimately recouped. This ruling overlooks the opportunity cost of holding a bond in an environment of
higher interest rates. It reflects, not surprisingly, an accounting view of a transaction rather an economic view.
Under SFAS 133, valuation of derivative instruments and the corresponding hedged instrument is critical.
SFAS 133 do not permit macro hedges. In a macro hedge, a firm takes all of its positions into account and
hedges the net exposure. For example, a firm could have exposures to a variety of asset classes. Due to correlations among those asset classes, there may be considerable risk reduction. The firm may then choose to hedge
only the remaining risk. Yet, such hedges will now no longer qualify for hedge accounting. Hedges must be
transaction specific. The conclusion is that if SFAS 133 forces firms to pay more attention to the market values
of their derivatives and their hedged instruments, it probably will serve a good purpose (Chance & Brooks,
2007).

3. SFAS 161 Disclosure Requirements for Derivatives & Hedging Activities
Evince from the DOW 30
In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133.” FASB Statement No.
161 provides disclosure requirements for derivative instruments and hedging activities and applies to all derivative instruments, including bifurcated derivative instruments and related hedged items accounted for under
FASB Statement No. 133. It amends and expands the previous disclosure requirements of FASB Statement No.
133 and is effective for interim periods beginning after November 15, 2008 and fiscal year that include those interim periods. This study examines the quarterly financial statements (10Qs) as of September 30, 2008 of the
thirty companies that comprise the Dow Jones Industrial Average to determine the extent to which these companies complied with the qualitative and quantitative disclosure requirements of SFAS No. 133 as amended by
SFAS No. 161 for derivative financial instruments. A surprising finding was that most companies failed with the
requirements of SFAS No. 133 to disclose the required information about cash flow hedges, net investments in
foreign operations and, fair value hedges.

3.1. SFAS 161 Disclosure Guidance
In an effort to assist financial statement users in better understanding the nature of an entity’s derivatives and
hedging transactions in the context of an entity’s risk exposures, the Financial Accounting Standards Board issued FASB Statement No. 161 to enhance derivative disclosures to enable users of financial statements to evaluate the success and significance of derivative instruments and hedging transactions on an entity’s financial
statements.
Amendments to FASB Statement No. 133: FASB Statement No. 161 contains extensive qualitative and quantitative disclosure requirements by requiring entities to provide transparency about: (1) “how and why an entity
uses derivative instruments”, (2) “how derivative instruments and related hedged items are justified under
Statement 133”, (3) “how derivative instruments and related hedged items affect an entity’s financial position,
financial performance, and cash flows” .To meet those objectives, FASB Statement No. 161 requires: (a) “qualitative disclosures about objectives and strategies for holding or issuing derivative instruments, the context
needed to understand those objectives, and the strategies for achieving those objectives”, (b) “the information
about derivative instruments should be disclosed by each instrument’s primary underlying risk exposure such as
interest rate risks, credit risks, foreign currency exchange rate risk, commodity price risk, equity price risk or
overall price risk”, (c) “derivative instruments should be distinguished between those used for risk management
purposes including those designated as hedging instruments and those used for other purposes”. Under SFAS No.
161, derivatives designated as hedging instruments should be classified as fair value hedging instruments, cash
flow hedging instruments, and foreign currency exposure hedging instruments, (d) information about the volume
of derivative activity (SFAS No. 161, p. 2).
Fair Value amounts of Derivative Instruments: Financial Accounting Standards Board Statement No. 133 as
amended by SFAS No. 161 requires all entities to recognize all of its derivative instruments as either assets or
liabilities in the statement of financial position at fair value. The accounting for changes in the fair value of a de-
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rivative instrument depends on whether it has been “designated and qualifying” as a hedging instrument or not
and fair value amounts should be presented separately by type of derivative contracts such as interest rate contracts, foreign exchange contracts, commodity contracts, credit contracts and other contracts. Also gains and
losses should be presented separately for derivative instruments “designated and qualifying” as hedging instruments in (a) “fair value hedges”, (b) “cash flow hedges”, and (c) derivative instruments not “designated or qualifying” as hedging instruments under this Statement (SFAS No. 161, pp. 4-5)
Fair Value Hedges: The Board acknowledged that for users of financial statements to deduce the full effects
of a “designated and qualifying” hedging transaction, information should be furnished about the location and
amount of gains and losses on hedged items that are reported in the statement of financial performance. The net
gain or loss identified in earnings in the reporting period should denote (a) “the amount of the hedges’ ineffectiveness and (b) “the component of the derivative instrument’s gain or loss, if any, excluded from the assessment
of hedge effectiveness” (SFAS No. 161, paragraph 45, p. 7).
Cash Flow Hedges: The effective allocation of the gain or loss on a derivative instrument that is “designated
and qualify” as a cash flow hedge should have stated as a constituent of other comprehensive income and reclassified into earnings in the same line item accompanying the forecasted transaction and in the same period or periods in which the hedged transaction influences earnings. The unexpended gain or loss on the derivative instrument remaining from the aggregate variations of the present value of future cash flows of the hedged item, if
any, or hedge components proscribed from the appraised effectiveness, should have recognized in the statement
of financial performance during the current period (SFAS No. 161, p. 8).

3.2. Research Questions
The research study addressed in the application component was adopted by the original research of Bhamornsiri
and Schroeder (2004), “The Disclosure of information on derivatives under SFAS No. 133, Evidence from the
Dow 30.” The research questions were redesigned to analyze the quarterly financial statements (10-Qs) filed
with the Securities and Exchange Commission (SEC) as of September 30, 2008 of the thirty companies that
comprise the Dow Jones Industrial Average, to determine whether the sample companies complied with the qualitative and quantitative disclosure requirements of SFAS No. 133 as amended by SFAS No. 161. Specifically,
the research questions include:
1. How many entities considered adopting SFAS No. 161?
2. Do the companies use:
a. Fair value hedges?
b. Cash flow hedges?
c. Foreign currency hedges to reduce market risk?
3. Do the companies comply with the qualitative requirements to disclose?
a. The fair value amounts of derivative instruments as separate asset and liability values segregated between derivatives that are “designated and qualifying” as hedging instruments and those that are not?
b. The line item(s) in the statement of financial position in which the fair value amounts of derivative instruments are included?
4. Do entities that account for derivative instruments and related hedged items under SFAS No. 133 disclose?
a. Quantitative and qualitative disclosures about market risk?
b. The entity’s objectives for holding or issuing derivative instruments?
c. The information about derivative instruments by each instrument’s primary underlying risk exposure?
5. Do companies comply with SFAS No. 161 requirements for fair value hedges to disclose?
a. The location of gain or loss recognized in income on derivative?
b. The amount of gain of loss recognized in income on derivative?
c. The ineffective amount of a fair value hedge?
6. Do companies comply with SFAS No. 161 requirements for cash flow hedges to disclose?
a. The amount of gain or loss recognized in OCI on derivative (effective portion)?
b. The location of gain or loss recognized in OCI on derivative (effective portion)?
c. The amount of gain or loss reclassified from accumulated OCI into income (effective portion)?
d. The amount and location of gain or loss recognized in income on derivative (ineffective portion and
amount excluded from effectiveness testing)?
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3.3. Results

For Research Questions 1 and 2, it can be observed from Table 1, that all the 30 companies comprising the Dow
Jones Industrial Average (30 Dow) reported using derivatives as part of their risk management strategy. Within
the 30 Dow companies a total of twenty-seven companies disclosed using fair value hedges, all thirty disclosed
using cash flow hedges and twenty disclosed the use of foreign exchange hedges. In addition, a total of seventeen of the 30 Dow companies disclosed adoption of SFAS No. 161 on January 1, 2009; ten companies did not
disclose implementation of SFAS No. 161, and only, three companies of the Dow 30 disclosed early implementation of SFAS No. 161 on November 15, 2008 including Citigroup, Inc., E.I. du Pont and Verizon.
From Table 2, we can detect a variation between the Dow 30 companies in compliance with the qualitative
requirements of SFAS No. 133 to disclose the fair value amounts of derivative financial instruments as separate
Table 1. Use of derivatives.
DOW30 Companies

Early Adoption
of SFAs 161

Fair Value
Hedge

Cash Flow
Hedge

Foreign Currency
Hedge

3M Co.

NO

YES

YES

NO

Alcoa Inc.

NO

YES

YES

NO

American Express Co.

YES

YES

YES

YES

AIG, Inc.

1/1/2009

YES

YES

YES

AT&T, Inc.

No

YES

YES

NO

Bank of America, Co.

No

YES

YES

NO

Boeing, Co.

No

YES

YES

NO

Caterpillar, Inc.

1/1/2009

YES

YES

YES

Chevron, Corp.

1/1/2009

YES

YES

YES

Citigroup, Inc.

11/15/2008

YES

YES

YES

E.I. du Pont

11/15/2008

YES

YES

YES

Exxon Mobile Corp.

YES

YES

YES

YES

GE Co.

YES

YES

YES

YES

General Motors, Corp.

1/1//2009

YES

YES

YES

Hewlett-Packard Co.

YEs

YES

YES

YES

Intel Corp.

1/1/2009

YES

YES

YES

IBM

1/1/2009

YES

YES

YES

Johnson & Johnson

NO

NO

YES

NO

JP Morgan & Chase & Co.

Yes

YES

YES

YES

McDolalds Corp.

NO

YES

YES

NO

Merck & Co., Inc.

1/1/2009

YES

YES

YES

Microsoft Corp.

1/1/2009

YES

YES

YES

Pfizer, Inc.

NO

YES

YES

NO

Coca-Cola Co.

NO

YES

YES

NO

Home Depot, Inc.

NO

NO

YES

NO

Procter & Gamble, Co.

1/1/2009

YES

YES

YES

United Technologies, Corp.

1/1/2009

YES

YES

YES

Verizon

11/15/2009

YES

YES

YES

Wal-Mart Stores, Inc.

1/1/2009

No

YES

YES

Walt Disney

1/1/2009

YES

YES

YES
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Table 2. Disclosures.
Asset/Liability Derivatives designated as Hedging Instruments under SFAS 133
DOW30 Companies

Objectives and
Risk Management
Policy

Description
of Items
been hedged?

Balance
Sheet
Location

Fair Value
of Derivative
Assets

3M Co.

YES

YES

FOOTNOTES

IMMATERIAL

Alcoa Inc.

YES

YES

FOOTNOTES

UNDISCLOSED
AMOUNT

American Express Co.

YES

YES

FOOTNOTES

YES

AIG, Inc.

YES

YES

FOOTNOTES

YES

AT&T, Inc.

YES

YES

FOOTNOTES

UNDISCLOSED
AMOUNT

Bank of America, Co.

YES

YES

FOOTNOTES

IMMATERIAL

Boeing, Co.

YES

YES

FOOTNOTES

IMMATERIAL

Caterpillar, Inc.

YES

YES

FOOTNOTES

YES

Chevron, Corp.

YES

YES

FOOTNOTES

YES

Citigroup, Inc.

YES

YES

FOOTNOTES

YES

E.I. du Pont

YES

YES

FOOTNOTES

YES

Exxon Mobile Corp.

YES

YES

FOOTNOTES

YES

GE Co.

YES

YES

FOOTNOTES

YES

General Motors, Corp.

YES

YES

FOOTNOTES

YES

Hewlett-Packard Co.

YES

YES

FOOTNOTES

YES

Intel Corp.

YES

YES

FOOTNOTES

YES

IBM

YES

YES

BALANCE SHEET

985

Johnson & Johnson

YES

YES

FOOTNOTES

UNDISCLOSED
AMOUNT

JP Morgan & Chase & CO.

YES

YES

FOOTNOTES

YES

McDonalds’ Corp.

YES

YES

BALANCE SHEET

(4.0)

Merck & Co., Inc.

YES

YES

FOOTNOTES

YES

Microsoft Corp.

YES

YES

FOOTNOTES

YES

Pfizer, Inc.

YES

YES

BALANCE SHEET

7152

Coca-Cola Co.

YES

YES

BALANCE SHEET

201

Home Depot, Inc.

YES

YES

BALANCE SHEET

315

Procter & Gamble, Co.

YES

YES

FOOTNOTES

UNDISCLOSED
AMOUNT

United Technologies, Corp.

YES

YES

FOOTNOTES

YES

Verizon

YES

YES

FOOTNOTES

YES

Wal-Mart Stores, Inc.

YES

YES

BALANCE SHEET

72

Walt Disney

YES

YES

BALANCE SHEET

(9)
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asset and liability values. Seven companies from the Dow 30 provided the fair value amounts of derivative assets and liabilities as a separate line item in the statement of financial position. Sixteen companies disclosed
their derivative financial instruments as a component of other assets and liabilities with supplemental footnote
disclosures while four companies indicated that the value of their derivative financial instruments was incorporated as an undisclosed amount of other assets and liabilities and the remaining three companies disclosed the
fair value of their derivative financial instruments as immaterial in the footnotes of their financial statements. As
shown in Table 2, all 30 Dow companies were found to comply with the qualitative requirements to disclose
their objectives for holding or issuing derivative financial instruments and risk management policy as well as a
description of the items being hedged. However, again there is a lack of consistency in the amount of disclosed
information since only several companies disclosed this information more clearly and extensively than others.
The following disclosures from two of the 30 Dow companies were quoted from their September 30, 2008
Quarterly Financial Statements (10Qs) to illustrate this point:
“Market risk is the risk to earnings or value resulting from movements in market prices. The Company’s
market risk consists primarily of interest rate risk in the card, insurance and certificate businesses and foreign exchange risk in international operations. As described in the Company’s Annual Report on Form
10-K for the year ended December 31, 2007 (see “Item 7A. Quantitative and Qualitative Disclosures About
Market Risk”), the detrimental effect on the Company’s pretax earnings of a hypothetical 100 basis point
increase in interest rates would be approximately $227 million, and of a 10 percent strengthening of the U.S.
dollar related to anticipated overseas operating results for the next 12 months would hypothetically be approximately $115 million, based on year-end positions. These sensitivities are based on the hypothetical
assumption that all relevant maturities and types of interest rates and foreign exchange rates that affect the
Company’s results would increase instantaneously and simultaneously and to the same degree. There were
no material changes in these market risks since December 31, 2007. The actual impact of interest rate and
foreign exchange rate changes will depend on, among other factors, the timing of rate changes, the extent to
which different rates do not move in the same direction or in the same direction to the same degree, and
changes in the volume and mix of the Company’s businesses” (American Express, 2008-10Q).
“At June 30, 2008, we had interest rate swaps with a notional value of $6000 and a fair value of $24. In
the second quarter we entered into an additional interest rate swaps with a notional amount of $2750. We
have fixed-to-fixed cross-currency swaps on foreign-currency-denominated debt instruments with a U.S.
dollar notional value of $4774 to hedge our exposure to changes in foreign currency exchange rates. The
increase in 2008 relates to our April 2008 entry into additional fixed-to-fixed cross-currency swaps on our
Euro-denominated global notes with a U.S. dollar notional value of $1975 to hedge our exposure to
changes in foreign currency exchange rates. This hedge also includes interest rate swaps of a fixed foreigndenominated rate to a fixed U.S.-denominated interest rate, which results in a U.S.-denominated semi-annual rate of 5.78% on our Euro-denominated notes. These derivatives have been designated at inception
and qualify as cash flow hedges with a net fair value of $112 at June 30, 2008” (AT & T, Inc., 2008-10Q).
From Table 3, it can be seen that the Dow 30 companies complied more consistently with the qualitative disclosure requirements of SFAS No. 133 in comparison to their erratic compliance with the SFAS No. 133 quantitative disclosure requirements. Only twelve companies of the Dow 30 that indicated the use of fair value
hedges recognized in income the amount of gain/loss on the derivative while sixteen companies did not disclose
any gain or loss in income by designated the fair value hedge as not significant or immaterial. Another problem
noticed was numerous companies did not specifically indicate the type of hedges been disclosed. However, since
SFAS No. 133 requires the effect of fair value hedges to be included in current earnings, these disclosures were
apparently related to the fair value hedges. In addition, only twelve companies of the Dow 30 disclosed the location of gain/loss recognized in income on derivative and only four companies disclosed the ineffective amount
of fair value hedges.
From Table 4, it can be seen that nineteen companies of the Dow 30 that indicated the use of cash flow
hedges recognized in other comprehensive income the amount of gain/loss on derivative, only seven companies
reclassified from accumulated other comprehensive income into income the effective portion of the amount of
gain or loss on the derivative and three companies recognized in income the gain or loss on derivative of the ineffective portion and amount excluded from the effectiveness testing.
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Table 3. Derivatives in SFAS No. 133 fair value hedging relationships.
Location of Gain/Loss
Recognized in
Income on Derivative

Amount of Gain/Loss
Recognized in Income on
Derivative (in millions)

Ineffective Amount

3M Co.

Not disclosed

Not disclosed

Not disclosed

Alcoa Inc.

Footnotes

(61)

Not disclosed

American Express Co.

Footnotes

(12)

Not disclosed

AIG, Inc.

Not disclosed

Not disclosed

Not disclosed

AT&T, Inc.

Footnotes

1.3

Not disclosed

Bank of America, Co.

Footnotes

(59)

Not disclosed

Boeing, Co.

Footnotes

(21)

(44)

Caterpillar, Inc.

Footnotes

(24)

100% Effective

Chevron, Corp.

Not disclosed

Not disclosed

Not disclosed

Citigroup, Inc.

Footnotes

85

168

E.I. du Pont

Not disclosed

Not disclosed

Not disclosed

Exxon Mobile Corp.

Not disclosed

Not disclosed

Not disclosed

GE Co.

Not disclosed

Not disclosed

Not disclosed

General Motors, Corp.

Not disclosed

Not disclosed

Not disclosed

Hewlett-Packard Co.

Footnotes

(99)

(218)

Intel Corp.

Footnotes

(25)

Not material

IBM

Not disclosed

Not disclosed

Not disclosed

Johnson & Johnson

Not disclosed

Not disclosed

Not disclosed

JP Morgan & Chase & Co.

Footnotes

604

(386)

McDolalds Corp.

Not disclosed

Not disclosed

Not disclosed

Merck & Co., Inc.

Not disclosed

Not disclosed

Not disclosed

Microsoft Corp.

Footnotes

(165)

Not disclosed

Pfizer, Inc.

Not disclosed

Not disclosed

Not disclosed

Coca-Cola Co.

Footnotes

125

Not material

Home Depot, Inc.

Not applicable

Not applicable

Not applicable

Procter & Gamble, Co.

Not applicable

Not applicable

Not applicable

United Technologies, Corp.

Not disclosed

Not disclosed

Not disclosed

Verizon

Not disclosed

Not disclosed

Not disclosed

Wal-Mart Stores, Inc.

Not disclosed

Not disclosed

Not disclosed

Walt Disney

Not disclosed

Not disclosed

Not disclosed
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Table 4. Cash flow hedges.
Amount of Gain/Loss
Recognized in OCI on
Derivative

Location/Amount of
Gain/Loss Reclassified
from Accumulated OCI
into Income
(Effective Portion)

Location/Amount of Gain/Loss
Recognized in Income on
Derivative (Ineffective
portion and Amount Excluded
from Effectiveness Testing)

3M Co.

Not disclosed

Not disclosed

Not disclosed

Alcoa Inc.

Not disclosed

Not disclosed

Not disclosed

American Express Co.

Not disclosed

Not disclosed

Not disclosed

AIG, Inc.

144

Not disclosed

Not disclosed

AT&T, Inc.

(21)

5

Not disclosed

Bank of America, Co.

Footnotes

(14)

(59)

Boeing, Co.

97

Not disclosed

Not disclosed

Caterpillar, Inc.

31

(35)

Not disclosed

Chevron, Corp.

Not disclosed

Not disclosed

Not disclosed

Citigroup, Inc.

(760)

Not disclosed

Not disclosed

E.I. du Pont

(124)

(81)

18

Exxon Mobile Corp.

Not disclosed

Not disclosed

Not disclosed

GE Co.

(202)

(32)

Not disclosed

General Motors, Corp.

93

116

Not disclosed

Hewlett-Packard Co.

11

Not disclosed

3

Intel Corp.

54

Not disclosed

Not disclosed

IBM

596

Not disclosed

Not disclosed

Johnson & Johnson

64

105

Not disclosed

JP Morgan & Chase & Co.

433

Not disclosed

Not disclosed

McDolalds Corp.

231

Not disclosed

Not disclosed

Merck & Co., Inc.

Not disclosed

Not disclosed

Not disclosed

Microsoft Corp.

293

Not disclosed

Not disclosed

Pfizer, Inc.

Not disclosed

Not disclosed

Not disclosed

Coca-Cola Co.

Not disclosed

Not disclosed

Not disclosed

Home Depot, Inc.

8

Not disclosed

Not disclosed

Procter & Gamble, Co.

Not applicable

Not applicable

Not disclosed

United Technologies, Corp.

Not disclosed

Not disclosed

Not disclosed

Verizon

(8)

Not disclosed

Not material

Wal-Mart Stores, Inc.

Not disclosed

Not disclosed

Not disclosed

Walt Disney

(59)

Not disclosed

Not disclosed

3.4. Discussion
This study studied the disclosure of information on the use of derivative financial instruments by Dow 30 companies under the provisions of SFAS No. 133 as amended by SFAS No. 161. According to the original research
of Bhamornsiri and Schroeder (2004), they deduced that the demonstrated companies consented with the qualit-
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ative disclosure requirements of SFAS No. 133. Consequently, financial statement users could value these companies’ policies for utilizing derivative financial instruments. However, the authors established that Dow 30 had
differences in encountering the quantitative requirements of SFAS No. 133 resulting in the inability of financial
statement users to assess the results of the companies’ strategies for using derivative financial instrument. Supplemental, the authors’ study of the quarterly financial statements of the Dow 30 compelled diversity among the
disclosure information of companies concerning the quantity of information disclosed, the place in the footnotes
of the information disclosed, and the presentation used to disclose the information about derivative financial instruments. The authors concluded that (a) “the lack of a clear understanding of the provisions of SFAS No. 133”,
(b) “the belief that some of the information was immaterial” and (c) “the desire to conceal potentially unfavorable information” were the practicable clarifications of their findings. In agreement to my analysis of the quarterly financial statements of the Dow 30 as of September 30, 2008, I concluded that the majority of companies misappropriated the specifications of SFAS No. 133 to disclose the required information about cash flow hedges,
net investments in foreign operations and, fair value hedges. Under Statement 133 the effective portion of a cash
flow hedge and a hedge of a net investment in a foreign operation should have deferred in OCI until the hedged
transaction influenced income, and the pertinent derivative value should reclassified from OCI into earnings to
edict the timing effect of the hedged item or hedged forecasted transaction. I concluded that most companies
failed to comply with the requirements of SFAS No. 133 to individually disclose the beginning and ending accumulated derivative gain or loss in accumulated other comprehensive income, the corresponding net changes of
the current hedging transactions, and the net amount of any reclassification into earnings. The firms mainly
trapped by incredulity where those employed cash flow hedges with interest rate swaps efficient for the “shortcut method” and those utilizing the “all-in-one” cash flow approach for commodity purchase and sale contracts
that met the definition of a derivative. Moreover, I comprehended by my analysis of the Dow 30 10-Q’s that
numerous companies that employed derivative instruments that were “designated and qualified” to hedge the
exposure to changes in the fair value of an asset or a liability, failed to disclose the gain or loss on the derivative
instrument in the same line item corresponding with the hedged item in current earnings. As it is stated in Ernst
& Young’s (2008) “Financial Reporting Developments for FASB Statement No. 161”, one of the great challenges companies visages on reporting derivative financial instruments on their financial statements sequels
from the Statement 133’s “micro” focus on individual transactions and individual hedged items. Statement 133
does not impose well-informed guidance to help management theorize its general organizational risk disclosures.
Most entities concentrate on risk disclosures from a macro-viewpoint while Statement 133 does not allow a macro, enterprise-extensive perspective for the use of derivative financial instruments. Hence, entities practice,
gather, and appoint a micro epitome of derivatives to accomplish the overall macro risk objectives. Also the unavailability of a recommended format of the disclosure requirements adds an additional constraint to companies’
visage of the implementation of SFAS No. 133. Although, Statement 161 gives qualitative and quantitative
samples to exemplify the application of the disclosure requirements entities have the versatility to present their
disclosures differently since these instances are not at a recommended format. SFAS No. 161 incorporates two
different “tabular formats” for quantitative disclosure requirements, one “balance sheet-centric” and one “income statement-centric”. These two tabular formats about disclosing the location and fair values of derivative
instruments and their corresponding gains and losses should grant a more complete representation and best convey a discernment of the impact of an entity’s use of derivatives on results of financial performance and cash
flows throughout the reporting period and on the financial position at period ends. Supplemental, Statement 161
requires the fair value amounts on a gross basis to be displayed as separate assets and liability values separated
among “designated & qualifying” instruments and those who are not, and by the type of contract to facilitate
readers of financial statements to better comprehend how the various risks are being administered.

3.5. Conclusion
SFAS No. 133 is famously criticized as being excessively difficult, very lengthy, and rules-based. SFAS No. 133
pertains to numerous pages of implementation instructions referring to the scope exceptions and interpretive
guidance on the definition of net settlement. The proposed Statement should restate the underlying principles of
derivative and hedging accounting and substantially decrease the length and difficulty of the standard. It is believed that the proposed Statement does not denote amelioration in financial reporting. While it is reputed that the
proposed modifications applying to simplifying the assessment of effectiveness utilizing principally qualitative
factors is an enhancement in financial reporting, conversely the proposed changes to hedge accounting for fi-
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nancial instruments which condemn the bifurcation-by-risk approach to qualifying for hedge accounting and to
estimating and recognizing ineffectiveness would intensify financial reporting for derivative financial instruments
(FASB Exposure Draft amendment of SFAS No. 133, 2008). In conclusion, as determined in the proposed
Statement (2008), “changes in the fair value of the derivative expected to reasonably offset all of the changes in
fair value or cash flows of a recognized derivative financial instrument for the relationship to qualify for hedge
accounting”. The proposed Statement may preclude some of the simple effective hedging strategies presently used
since derivatives are designed to manage only distinct risks such as interest rates and not all risks. Even if the
derivative was estimated to grant “reasonable offset”, the entity would have to recognize changes in the value of
the hedged item or forecasted transaction relating to unhedged risks, which would not have been recognized if
hedge accounting had not been designated. This change mostly influences hedges of interest-earning assets and
interest-bearing liabilities that are hedged after inception and forecasted transactions involving debt instruments.
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